A large analysis looked at patients with rectal cancer who received treatment before surgery. Researchers examined MRI scans taken after this initial treatment to check for specific signs of remaining cancer. They focused on persistent extramural venous invasion and tumor deposits, comparing these signs to the status of lymph nodes after treatment.
The study found that patients with these persistent MRI signs had significantly lower disease-free and overall survival. Specifically, persistent extramural venous invasion was linked to worse outcomes, as was the presence of tumor deposits. In contrast, the status of lymph nodes after treatment showed inconsistent associations with survival in this analysis.
This research highlights that these specific MRI markers are important for understanding patient risk. The authors note that the clinical meaning of these persistent signs is not fully defined. They argue that using these markers in risk assessment and trial design is urgently needed to guide personalized treatment strategies for rectal cancer patients.
